News

Medpage Today on MSN6mon
FDA Approves New Option for Rosacea
The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...
Minocycline (as HCl) 45mg, 55mg, 65mg, 80mg, 90mg, 105mg, 115mg, 135mg. Swallow whole. Give approximately 1mg/kg once daily for 12wks. Weight-based dosing (45–49kg ...
The new capsule formulation of the antibiotic minocycline hydrochloride has been cleared by the US regulator to treat the inflammatory lesions caused by rosacea – which causes flushing or long ...
An increasing amount of evidence suggests that the FDA-approved antibiotic minocycline might have neuroprotective effects in animal models of various neurodegenerative disorders, and Gordon et al.